Issue 3/2024
Content (21 Articles)
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
Masaya Hattori, Naoko Honma, Shigenori Nagai, Kazutaka Narui, Tomoko Shigechi, Yukinori Ozaki, Masayuki Yoshida, Takashi Sakatani, Eiichi Sasaki, Yuko Tanabe, Junji Tsurutani, Toshimi Takano, Shigehira Saji, Shinobu Masuda, Rie Horii, Hitoshi Tsuda, Rin Yamaguchi, Tatsuya Toyama, Chikako Yamauchi, Masakazu Toi, Yutaka Yamamoto
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment
Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai, Takehiko Sakai, Goro Kutomi, Michio Yoshimura, Masaaki Kawai, Shoichiro Ohtani, Kazunori Kubota, Kazutaka Nakashima, Naoko Honma, Masayuki Yoshida, Eriko Tokunaga, Naruto Taira, Hiroji Iwata, Shigehira Saji
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition
Michio Yoshimura, Chikako Yamauchi, Naoko Sanuki, Yasushi Hamamoto, Kimiko Hirata, Jiro Kawamori, Mariko Kawamura, Mami Ogita, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer
Xue Hu
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models
Hongyan Zheng, Lihua Wu, Jianfeng Chen, Na Na, Ge Lou
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer
Kazuhiko Sato, Hiromi Fuchikami, Naoko Takeda, Nana Natsume, Masahiro Kato
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants
Nalee Kim, Won Kyung Cho, Won Park, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu, Eun Sook Ko, Haeyoung Kim
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan
Yasue Tsuchida, Naoki Niikura, Takashi Chishima, Mari Mizuno, Takahiko Kawate, Hiromi Fuchikami, Yasuo Miyoshi, Takehiko Sakai, Haruru Kotani, Naoto Kondo, Naoki Hayashi
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer
Kumiko Kida, Akimitsu Yamada, Kazuhiro Shimada, Kazutaka Narui, Sadatoshi Sugae, Daisuke Shimizu, Takako Doi, Mari Oba, Itaru Endo, Takashi Ishikawa
The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer
Jin-hui Ye, Jian Yu, Ming-ying Huang, Yue-mei Mo
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB
Guo Li, Xinyue Lin, Xinpeng Wang, Lvjuan Cai, Jianren Liu, Yunyun Zhu, Zhichao Fu
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β
Monalisa Parija, Surya Prakash, B. Madhu Krishna, Sanghamitra Dash, Sandip K. Mishra
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap
Joep A. F. van Rooij, Ennie Bijkerk, René R. J. W. van der Hulst, Stefania M. H. Tuinder
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile
Danbee Kang, Seri Park, Hyo Jung Kim, Jiseon Lee, Jiyoon Han, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer
Kazutaka Narui, Toshihiko Satake, Takashi Ishikawa, Mayu Muto, Yui Tsunoda, Akimitsu Yamada, Kei Kawashima, Natsuki Uenaka, Yoshie Fujiwara, Masanori Oshi, Shoko Adachi, Chiho Suzuki, Tomoko Wada, Shinya Yamamoto, Mikiko Tanabe, Jiro Maegawa, Itaru Endo
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer
Kim Vo, Colton Ladbury, Stephanie Yoon, Jose Bazan, Scott Glaser, Arya Amini
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy
Hiroko Nogi, Akiko Ogiya, Makoto Ishitobi, Chikako Yamauchi, Hiroki Mori, Ayaka Shimo, Kazutaka Narui, Naomi Nagura, Hirohito Seki, Shinsuke Sasada, Teruhisa Sakurai, Tadahiko Shien
Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy
Dan Lin, Kathleen M. Sturgeon, Joshua E. Muscat, Shouhao Zhou, Andrea L. Hobkirk, Katie M. O’Brien, Dale P. Sandler, Cheryl L. Thompson
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer
Sean M. Hacking, Gabrielle Windsor, Robert Cooper, Zhicheng Jiao, Ana Lourenco, Yihong Wang
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.
Reiko Fukui, Takahiro Watanabe, Koji Morimoto, Yukie Fujimoto, Masayuki Nagahashi, Eri Ishikawa, Seiichi Hirota, Yasuo Miyoshi